BioHealth News Archive
Phlow Included in BARDA Contract Development and Manufacturing Organization Network to Provide Domestic API Capability for Essential Medicines and Medical Countermeasures
Phlow is strategically working with the U.S. government to ensure preparedness for future national health crises October 20, 2021 09:00 AM Eastern Daylight…
Read More
935 Prose – The Next Evolution of Innovaiton
935 Prose is a 10-story trophy-class, state-of-the-art research/lab building that marries iconic design, and superior lab functionality. It is positioned to recruit and retain…
Read More
FORBES Magazine Insert – Maryland: A Magnet For Innovation by State of Maryland – issuu
This Forbes special section showcases how the state continues to step up its game to keep businesses thriving. Maryland's dynamic and ever-growing aerospace, cybersecurity,…
Read More
2021 BPI Readers’ Choice Awards
Each year BioProcess International publishes over 150 articles focusing on the latest science, technologies, and techniques supporting biopharmaceutical research, development, and manufacturing. As publishers,…
Read More
America on Edge: Settling for Second Place?
The United States is on edge in ways the nation has rarely experienced throughout its young history. The country’s global leadership is being challenged…
Read More
BioTalk Welcomes Mr. Hakdo Kim, President, Korea SMEs & Startups Agency KOSME)
Mr. Hakdo Kim, President, Korea SMEs & Startups Agency KOSME), joins Rich Bendis from the BHI Offices to discuss their biotech mission, their relationship…
Read More
Maryland E-Nnovation Grant Supports Medical Research
October 20, 2021 | By Deborah Kotz University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that UMSOM has been…
Read More
Danae Partners with Materic, Receives Follow-on Investment from Conscious Venture Partners
Danae expands its 3-D Print manufacturing capacity, adds access to unique 3D printing technologies from Materic October 21, 2021, Baltimore, MD – Danae, Inc., a Baltimore-based…
Read More
D&D Pharmatech Raises $51M in Series C Financing to Advance Potential Disease-Modifying Treatments for Neurodegenerative, Fibrotic, and Metabolic Diseases
GYEONGGI-DO, Korea & GAITHERSBURG, Md., October 19, 2021--(BUSINESS WIRE)--D&D Pharmatech Inc., a clinical-stage biotechnology company focused on development and commercialization of revolutionary medicines, and…
Read More
BioHealth Innovation Appoints Aubrey Watkins III, Ph.D., M.S. to Board of Directors
ROCKVILLE, MARYLAND, Oct 18, 2020 – The Board of Directors of BioHealth Innovation, Inc. (BHI) unanimously approved the appointment of Aubrey Watkins III, Ph.D.,…
Read More
2021 Forum Videos are Now Available!
Leaders from the BioHealth Capital Region welcome the over 1,000 registrants to the 7th Annual BioHealth Capital Region Forum. Please visit this link.
Read More
A US – UK Discussion: How to Conduct Clinical Trials as Seth Toback, Vice President, Clinical Development at Novavax and Divya Chadha Manek, Director of Business Development at the National Institute for Health Research (NIHR) join Rich Bendis on BioTalk.
Listen now via Apple https://apple.co/3BSIFjn, Google https://bit.ly/3j7YyLt, Spotify https://spoti.fi/2Z474Ec, and TuneIn https://bit.ly/3DUweUz. Divya Chadha Manek was appointed as the NIHR CRN’s Head of Commercial Business Development in 2015 then…
Read More
Life Sciences Business Strategist – Open Position!
BioHealth Innovation (BHI) is an innovation intermediary that facilitates the commercialization of emerging technologies in the BioHealth Capital Region (Maryland, DC and Virginia). BHI…
Read More
Mapping the Medical Device Start-up Ecosystem | by John G Younger | Bioeconomy.XYZ | Oct, 2021 | Medium
Medical devices are ubiquitous in US healthcare— everything from the delivery room’s sterile gloves and umbilical cord clamps to the breathtakingly sophisticated neurosurgical operating…
Read More
Distrust, Fear Hamper COVID Vaccinations, Clinical Trial Diversity
TYSONS CORNER, Va., Oct. 12, 2021 /PRNewswire-PRWeb/ -- As of late September, 77% of the total adult population of the U.S. had received at…
Read More